Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Prostate Cancer

  Free Subscription


27.12.2021

1 Acta Radiol
2 AJR Am J Roentgenol
2 BJU Int
2 BMC Cancer
5 Br J Cancer
1 Cancer
2 Cancer Res
1 Clin Cancer Res
1 Eur Radiol
6 Eur Urol
2 Hum Pathol
1 Int J Oncol
3 Int J Radiat Oncol Biol Phys
2 J Clin Oncol
3 J Magn Reson Imaging
2 J Nucl Med
1 J Urol
4 N Engl J Med
2 Nat Rev Urol
1 Oncogene
1 PLoS Comput Biol
1 PLoS One
1 Proc Natl Acad Sci U S A
3 Prog Urol
5 Prostate
2 Radiology
2 Urol Int
1 Urology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Radiol

  1. THOMSEN HS
    International Scientific Prize.
    Acta Radiol. 2021;62:1131.
    PubMed        


    AJR Am J Roentgenol

  2. CHANG SD, Ghai S, Kim CK, Oto A, et al
    MRI-Targeted Prostate Biopsy Techniques: AJR Expert Panel Narrative Review.
    AJR Am J Roentgenol. 2021 Jul 14. doi: 10.2214/AJR.21.26154.
    PubMed         Abstract available

  3. CUOCOLO R
    Editorial Comment: Prostate Cancer Detection With Machine Learning-Still More Challenges Than Opportunities.
    AJR Am J Roentgenol. 2021 Dec 22. doi: 10.2214/AJR.21.27221.
    PubMed        


    BJU Int

  4. SINGH S, Sandhu P, Beckmann K, Santaolalla A, et al
    Negative first follow-up prostate biopsy on active surveillance is associated with decreased risk of upgrading, suspicion of progression and converting to active treatment.
    BJU Int. 2021;128:72-78.
    PubMed         Abstract available

  5. MOTTRIE A, Mazzone E, Wiklund P, Graefen M, et al
    Objective assessment of intraoperative skills for robot-assisted radical prostatectomy (RARP): results from the ERUS Scientific and Educational Working Groups Metrics Initiative.
    BJU Int. 2021;128:103-111.
    PubMed         Abstract available


    BMC Cancer

  6. LIU AY
    The opposing action of stromal cell proenkephalin and stem cell transcription factors in prostate cancer differentiation.
    BMC Cancer. 2021;21:1335.
    PubMed         Abstract available

  7. SCHNEPP PM, Ahmed A, Escara-Wilke J, Dai J, et al
    Transcription factor network analysis based on single cell RNA-seq identifies that Trichostatin-a reverses docetaxel resistance in prostate Cancer.
    BMC Cancer. 2021;21:1316.
    PubMed         Abstract available


    Br J Cancer

  8. CHEN F, Han Y, Kang Y
    Bone marrow niches in the regulation of bone metastasis.
    Br J Cancer. 2021;124:1912-1920.
    PubMed         Abstract available

  9. AMADOU A, Freisling H, Jenab M, Tsilidis KK, et al
    Prevalent diabetes and risk of total, colorectal, prostate and breast cancers in an ageing population: meta-analysis of individual participant data from cohorts of the CHANCES consortium.
    Br J Cancer. 2021;124:1882-1890.
    PubMed         Abstract available

  10. LIU Z, Thong MSY, Doege D, Koch-Gallenkamp L, et al
    Prevalence of benefit finding and posttraumatic growth in long-term cancer survivors: results from a multi-regional population-based survey in Germany.
    Br J Cancer. 2021;125:877-883.
    PubMed         Abstract available

  11. SLOOTBEEK PHJ, Kloots ISH, Smits M, van Oort IM, et al
    Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
    Br J Cancer. 2021 Dec 15. pii: 10.1038/s41416-021-01663.
    PubMed         Abstract available

  12. MCHUGH J, Saunders EJ, Dadaev T, McGrowder E, et al
    Prostate cancer risk in men of differing genetic ancestry and approaches to disease screening and management in these groups.
    Br J Cancer. 2021 Dec 18. pii: 10.1038/s41416-021-01669.
    PubMed         Abstract available


    Cancer

  13. TILBURT JC, Zahrieh D, Pacyna JE, Petereit DG, et al
    Decision aids for localized prostate cancer in diverse minority men: Primary outcome results from a multicenter cancer care delivery trial (Alliance A191402CD).
    Cancer. 2021 Dec 10. doi: 10.1002/cncr.34062.
    PubMed         Abstract available


    Cancer Res

  14. STEINER MC, Marston JL, Iniguez LP, Bendall ML, et al
    Locus-Specific Characterization of Human Endogenous Retrovirus Expression in Prostate, Breast, and Colon Cancers.
    Cancer Res. 2021;81:3449-3460.
    PubMed         Abstract available

  15. TAKAYAMA KI, Honma T, Suzuki T, Kondoh Y, et al
    Targeting Epigenetic and Posttranscriptional Gene Regulation by PSF Impairs Hormone Therapy-Refractory Cancer Growth.
    Cancer Res. 2021;81:3495-3508.
    PubMed         Abstract available


    Clin Cancer Res

  16. BERCHUCK JE, Baca SC, McClure HM, Korthauer K, et al
    Detecting neuroendocrine prostate cancer through tissue-informed cell-free DNA methylation analysis.
    Clin Cancer Res. 2021 Dec 14. pii: 1078-0432.CCR-21-3762.
    PubMed         Abstract available


    Eur Radiol

  17. MICHALLEK F, Huisman H, Hamm B, Elezkurtaj S, et al
    Prediction of prostate cancer grade using fractal analysis of perfusion MRI: retrospective proof-of-principle study.
    Eur Radiol. 2021 Dec 16. pii: 10.1007/s00330-021-08394.
    PubMed         Abstract available


    Eur Urol

  18. CASTRO E
    TP53: Another Piece of the Prostate Cancer Genetics Puzzle.
    Eur Urol. 2021 Dec 9. pii: S0302-2838(21)02199.
    PubMed        

  19. SBIZZERA M, Morel-Journel N, Carnicelli D, Ruffion A, et al
    Reply to Jas Singh's Letter to the Editor re: Marc Sbizzera, Nicolas Morel-Journel, Alain Ruffion, et al. Rectourethral Fistula Induced by Localised Prostate Cancer Treatment: Surgical and Functional Outcomes of Transperineal Repair with Gracilis Musc
    Eur Urol. 2021 Dec 18. pii: S0302-2838(21)02209.
    PubMed        

  20. GRUMMET J, Eggener S
    Re: NCCN Prostate Cancer Guidelines Version 1.2022 - September 10, 2021.
    Eur Urol. 2021 Dec 9. pii: S0302-2838(21)02201.
    PubMed        

  21. OST P, Siva S, Zilli T
    Everything But the Kitchen Sink: Comprehensive Nodal Irradiation with Androgen Deprivation in OLIGOPELVIS.
    Eur Urol. 2021;80:415-416.
    PubMed        

  22. SWAMI U, Sayegh N, Agarwal N
    Development of Novel Regimens Combining Immune Checkpoint Inhibitors and Radiation Therapy in Prostate Cancer.
    Eur Urol. 2021 Dec 8. pii: S0302-2838(21)02200.
    PubMed        

  23. FASULO V, Zuradelli M, Lazzeri M
    Re: A Prospective Prostate Cancer Screening Programme for Men with Pathogenic Variants in Mismatch Repair Genes (IMPACT): Initial Results from an International Prospective Study.
    Eur Urol. 2021 Dec 9. pii: S0302-2838(21)02206.
    PubMed        


    Hum Pathol

  24. OFFERMANN A, Joerg V, Hupe MC, Becker F, et al
    CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia.
    Hum Pathol. 2021 Jul 24. pii: S0046-8177(21)00128.
    PubMed         Abstract available

  25. WU CL, Kim M, Wu S, Lin SX, et al
    Transperineal multiparametric magnetic resonance imaging-ultrasound fusion-targeted prostate biopsy combined with standard template improves perineural invasion detection.
    Hum Pathol. 2021;117:101-107.
    PubMed         Abstract available


    Int J Oncol

  26. LU S, Dong Z
    Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptormediated signaling.
    Int J Oncol. 2021;59.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  27. GLICKSMAN RM, Berlin A
    FACE Value of Patient-Reported Outcomes in Dose-Escalated Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2022;112:93-95.
    PubMed        

  28. ROY S, Zaorsky NG, Bagshaw HP, Berlin A, et al
    An Expert Review on the Combination of Relugolix with Definitive Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Dec 16. pii: S0360-3016(21)03240.
    PubMed         Abstract available

  29. HALL WA, Deshmukh S, Bruner DW, Michalski JM, et al
    Quality of Life Implications of Dose-Escalated External Beam Radiation for Localized Prostate Cancer: Results of a Prospective Randomized Phase 3 Clinical Trial, NRG/RTOG 0126.
    Int J Radiat Oncol Biol Phys. 2022;112:83-92.
    PubMed         Abstract available


    J Clin Oncol

  30. SADA YH
    A Dozen Eggs.
    J Clin Oncol. 2021;39:3645-3646.
    PubMed        

  31. STOCKLER MR, Martin AJ, Davis ID, Dhillon HM, et al
    Health-Related Quality of Life in Metastatic, Hormone-Sensitive Prostate Cancer: ENZAMET (ANZUP 1304), an International, Randomized Phase III Trial Led by ANZUP.
    J Clin Oncol. 2021 Dec 20:JCO2100941. doi: 10.1200/JCO.21.00941.
    PubMed         Abstract available


    J Magn Reson Imaging

  32. YUNAIYAMA D, Okubo M, Saito K
    Editorial for "Longitudinal Multiparametric Magnetic Resonance Imaging Assessment of Irradiated Salivary Gland in a Rat Model: Correlated with Histological Findings".
    J Magn Reson Imaging. 2021 Jul 17. doi: 10.1002/jmri.27837.
    PubMed        

  33. SATHIADOSS P, Schieda N, Haroon M, Osman H, et al
    Utility of Quantitative T2-Mapping Compared to Conventional and Advanced Diffusion Weighted Imaging Techniques for Multiparametric Prostate MRI in Men with Hip Prosthesis.
    J Magn Reson Imaging. 2021 Jul 5. doi: 10.1002/jmri.27803.
    PubMed         Abstract available

  34. ZHENG H, Miao Q, Liu Y, Raman SS, et al
    Integrative Machine Learning Prediction of Prostate Biopsy Results From Negative Multiparametric MRI.
    J Magn Reson Imaging. 2021 Jun 23. doi: 10.1002/jmri.27793.
    PubMed         Abstract available


    J Nucl Med

  35. SCHUCHARDT C, Zhang J, Kulkarni HR, Chen X, et al
    Prostate-specific membrane antigen radioligand therapy using (177)Lu-PSMA I&T and (177)Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer: comparison of safety, biodistribution and dosimetry.
    J Nucl Med. 2021 Dec 9. pii: jnumed.121.262713. doi: 10.2967/jnumed.121.262713.
    PubMed         Abstract available

  36. MENA E, Rowe SP, Shih JH, Lindenberg L, et al
    Predictors of (18)F-DCFPyL-PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy.
    J Nucl Med. 2021 Dec 16. pii: jnumed.121.262347. doi: 10.2967/jnumed.121.262347.
    PubMed         Abstract available


    J Urol

  37. TANEJA SS
    Urological Oncology: Prostate Cancer.
    J Urol. 2021 Dec 17:101097JU0000000000002377. doi: 10.1097/JU.0000000000002377.
    PubMed        


    N Engl J Med

  38. KASHIHARA T, Kashihara K
    Lutetium-177-PSMA-617 for Prostate Cancer.
    N Engl J Med. 2021;385:2494-2495.
    PubMed        

  39. SARTOR O, Morris MJ, Kraus BJ
    Lutetium-177-PSMA-617 for Prostate Cancer. Reply.
    N Engl J Med. 2021;385:2495-2496.
    PubMed        

  40. DALLA VOLTA A, Grisanti S, Berruti A
    Lutetium-177-PSMA-617 for Prostate Cancer.
    N Engl J Med. 2021;385:2495.
    PubMed        

  41. HINDIE E
    Lutetium-177-PSMA-617 for Prostate Cancer.
    N Engl J Med. 2021;385:2494.
    PubMed        


    Nat Rev Urol

  42. THOMAS T
    Metabolic response to immunotherapy in prostate cancer.
    Nat Rev Urol. 2021 Dec 8. pii: 10.1038/s41585-021-00550.
    PubMed        

  43. MASONE MC
    CSN5 as a clinical target in prostate cancer.
    Nat Rev Urol. 2021 Dec 9. pii: 10.1038/s41585-021-00552.
    PubMed        


    Oncogene

  44. MIRZAKHANI K, Kallenbach J, Rasa SMM, Ribaudo F, et al
    Correction to: The androgen receptor-lncRNASAT1-AKT-p15 axis mediates androgen-induced cellular senescence in prostate cancer cells.
    Oncogene. 2021 Dec 20. pii: 10.1038/s41388-021-02125.
    PubMed        


    PLoS Comput Biol

  45. CHARMPI K, Chokkalingam M, Johnen R, Beyer A, et al
    Optimizing network propagation for multi-omics data integration.
    PLoS Comput Biol. 2021;17:e1009161.
    PubMed         Abstract available


    PLoS One

  46. KLOSE K, Packeiser EM, Muller P, Granados-Soler JL, et al
    Metformin and sodium dichloroacetate effects on proliferation, apoptosis, and metabolic activity tested alone and in combination in a canine prostate and a bladder cancer cell line.
    PLoS One. 2021;16:e0257403.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  47. FENG W, Cao Z, Lim PX, Zhao H, et al
    Rapid interrogation of cancer cell of origin through CRISPR editing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Prog Urol

  48. DIAMANT E, de la Taille A, Lavolle A, Chahwan C, et al
    [Urethro-vesical anastomosis reconstruction using extra-peritoneal robot-assisted laparoscopy for anastomotic stenosis after radical prostatectomy].
    Prog Urol. 2021;31:591-597.
    PubMed         Abstract available

  49. PRUDHOMME T, Roumiguie M, Pericart S, Doumerc N, et al
    Assessment of oncological and functional outcomes of retropubic radical prostatectomy: An academic center experience.
    Prog Urol. 2021;31:1123-1132.
    PubMed         Abstract available

  50. LE BIHAN E, Derman J, Salomon L, De La Taille A, et al
    [Radical prostatectomy in patients with Gleason 6 (ISUP 1) prostate cancer: 10-year follow-up].
    Prog Urol. 2021 Dec 14. pii: S1166-7087(21)00569.
    PubMed         Abstract available


    Prostate

  51. HE H, Han D, Xu F, Lyu J, et al
    How socioeconomic and clinical factors impact prostate-cancer-specific and other-cause mortality in prostate cancer stratified by clinical stage: Competing-risk analysis.
    Prostate. 2021 Dec 20. doi: 10.1002/pros.24287.
    PubMed         Abstract available

  52. URABE F, Miki K, Kimura T, Sasaki H, et al
    Clinical significance of unfavorable findings in intermediate-risk prostate cancer patients for predicting treatment outcomes after contemporary, dose-escalated multimodal radiotherapy.
    Prostate. 2021 Dec 16. doi: 10.1002/pros.24289.
    PubMed         Abstract available

  53. KAUFMANN B, Saba K, Schmidli TS, Stutz S, et al
    Prostate cancer detection rate in men undergoing transperineal template-guided saturation and targeted prostate biopsy.
    Prostate. 2021 Dec 16. doi: 10.1002/pros.24286.
    PubMed         Abstract available

  54. BARLOW SK, Oyekunle T, Janes JL, De Hoedt AM, et al
    Prostate weight and prostate cancer outcomes after radical prostatectomy: Results from the SEARCH cohort study.
    Prostate. 2021 Dec 14. doi: 10.1002/pros.24283.
    PubMed         Abstract available

  55. LEFEBVRE F, Blanchet-Deverly A, Michineau L, Blanchet P, et al
    Metabolic syndrome and prostate cancer in Afro-Caribbean men.
    Prostate. 2021 Dec 14:e24281. doi: 10.1002/pros.24281.
    PubMed         Abstract available


    Radiology

  56. GOTTLIEB RH
    Introducing a Standard in Prostate Cancer Imaging Evaluation.
    Radiology. 2021 Dec 21:212111. doi: 10.1148/radiol.212111.
    PubMed        

  57. WIBMER AG, Nikolovski I, Chaim J, Lakhman Y, et al
    Local Extent of Prostate Cancer at MRI versus Prostatectomy Histopathology: Associations with Long-term Oncologic Outcomes.
    Radiology. 2021 Dec 21:210875. doi: 10.1148/radiol.210875.
    PubMed         Abstract available


    Urol Int

  58. CROCEROSSA F, Carbonara U, Parekh J, Urdaneta A, et al
    PSA and PSA Kinetics as Predictors for 18F-Fluciclovine PET/CT Positivity in Biochemically Recurrent Prostate Cancer.
    Urol Int. 2021 Dec 21:1-8. doi: 10.1159/000520684.
    PubMed         Abstract available

  59. BERG S, Tully KH, von Landenberg N, Bahlburg H, et al
    How Many Cores Should Be Sampled during Systematic Prostate Biopsy in Case of Negative Multiparametric Magnetic Resonance Imaging? Analysis of 274 Men with Clinical Suspicion of Prostate Cancer.
    Urol Int. 2021 Dec 20:1-6. doi: 10.1159/000520598.
    PubMed         Abstract available


    Urology

  60. WITTMANN D, Varlamos C, Rodriguez-Galano N, Day L, et al
    Developing a Patient-Centered Model of Prostate Cancer Care: Patient Satisfaction with a Survivorship Program Embedded in Urologic-oncologic Care.
    Urology. 2021 Dec 8. pii: S0090-4295(21)01153.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: